News

A new trial is testing whether nipocalimab can lower the risk of severe bleeding and death in babies at risk of FNAIT.

A study of genetic data from the Saudi population found that the predicted risk of FNAIT does not always align with observed outcomes.

Scientists developed a new technique to detect platelet antigens linked to FNAIT and quantify fetal DNA in maternal blood samples.

A highly sensitive genetic testing technology could make prenatal testing for conditions like FNAIT both safer and more accessible.

Stronger communication with staff can ease stress, improve trust and help parents feel more involved in their child’s care.

Of the staff surveyed, 92% said noise harms infants, while 76% linked it to errors in care caused by distracted or overwhelmed clinicians.

Researchers in Norway called for countries to update their guidelines to include consideration of anti-HPA-1a levels when treating FNAIT.

A study presents six cases of pregnant women with severe ITP, highlighting the importance of individualized treatment to improve outcomes.

In mothers with FNAIT, antibodies attach much more strongly to platelet proteins than to proteins on blood vessel cells.

In areas where the MAIPA test is unavailable, platelet crossmatching can be a useful tool for diagnosing FNAIT.